Brouillard F, Tondelier D, Edelman A, Baudouin-Legros M
Institut National de la Santé et de la Recherche Médicale U.467, Faculté de Médecine Necker, Paris, France.
Cancer Res. 2001 Feb 15;61(4):1693-8.
The inhibition of the Na+/K+-ATPase by cardiotonic drugs like ouabain deeply perturbs both the properties of the cell membrane and the ionic composition of the cytoplasm and hence alters fundamental cell reactions. These three types of reactions may be involved in the stimulation of multidrug resistance 1 (MDR-1) gene expression and the synthesis of permeability glycoprotein [P-glycoprotein (P-gp)]. We have determined whether ouabain, which binds to an extracellular motif of the Na+/K+-ATPase, stimulates MDR-1 gene expression by measuring both mRNA and protein and whether the resulting P-gp extrudes hydrophobic compounds and causes resistance to antimitotic agents. The experiments were performed on Calu-3 cells, a human cell line from a pulmonary carcinoma. Northern blotting showed that treating the cells with submicromolar concentrations of ouabain stimulated MDR-1 gene expression within 24 h. The ouabain-induced stimulation of MDR-1 expression was not restricted to Calu-3 cells but also occurred in human carcinomatous colon (T-84 and HT-29) and hepatic (H7V3) cells. However, it is not ubiquitous because it was not found in HeLa cells. The stimulation was reproduced by other Na+/K+-ATPase inhibitors and occurred via enhanced gene transcription, apparently due to the increased cytosolic calcium concentration. Ouabain also increased the membrane content of P-gp, as detected by immunoblotting and immunohistology. We have developed a microvideo assay based on the properties of acetoxymethyl ester calcein and calcein to show that this P-gp extruded the hydrophobic acetoxymethyl ester calcein. Ouabain also caused the Calu-3 cells to become resistant to doxorubicin and vinblastine. Thus, although ouabain acts extracellularly, it may stimulate MDR-1 gene expression and P-gp synthesis and make cells resistant to hydrophobic cytotoxic compounds.
哇巴因等强心药物对钠钾ATP酶的抑制作用会严重扰乱细胞膜的特性和细胞质的离子组成,从而改变细胞的基本反应。这三种类型的反应可能参与了多药耐药1(MDR-1)基因表达的刺激以及通透性糖蛋白[P-糖蛋白(P-gp)]的合成。我们通过测量mRNA和蛋白质来确定与钠钾ATP酶细胞外基序结合的哇巴因是否刺激MDR-1基因表达,以及由此产生的P-gp是否能排出疏水性化合物并导致对抗有丝分裂剂产生抗性。实验是在Calu-3细胞上进行的,这是一种来自肺癌的人类细胞系。Northern印迹法显示,用亚微摩尔浓度的哇巴因处理细胞在24小时内刺激了MDR-1基因表达。哇巴因诱导的MDR-1表达刺激并不局限于Calu-3细胞;在人结肠癌(T-84和HT-29)和肝癌(H7V3)细胞中也会发生。然而,它并非普遍存在,因为在HeLa细胞中未发现这种现象。其他钠钾ATP酶抑制剂也能重现这种刺激,并且这种刺激是通过增强基因转录发生的,显然是由于细胞质钙浓度增加所致。通过免疫印迹和免疫组织学检测发现,哇巴因还增加了P-gp的膜含量。我们基于乙酰氧基甲基酯钙黄绿素和钙黄绿素的特性开发了一种显微视频检测方法,以表明这种P-gp能排出疏水性的乙酰氧基甲基酯钙黄绿素。哇巴因还使Calu-3细胞对多柔比星和长春碱产生抗性。因此,尽管哇巴因在细胞外起作用,但它可能刺激MDR-1基因表达和P-gp合成,并使细胞对疏水性细胞毒性化合物产生抗性。